Skip to content

Shwadanshtradi rasayan for post covid -19 syndrome

A Randomized Open Label Single Group Clinical Trial to Evaluate the Efficacy of Shwadanshtradi Rasayan in Rasakshay of Post Covid-19 patients.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037338
Enrollment
35
Registered
2021-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Ashtang Ayurved Pharmacy Dhule
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Patients of Post Covid-19 came under duration of > 21 days to 1 year after RTPCR report. ii) Patients of Post covid â?? 19 showing classic feature of Rasakshay[23]. iii) Patients between age group of 18-70 years will be included. iv) The patients will be included after Shodhana.

Exclusion criteria

Exclusion criteria: Patients with serious life threatening diseases will be Excluded. ii) Patients with age group below 18 and above 70 will be excluded. iii) Pregnant women , children will be Excluded.

Design outcomes

Primary

MeasureTime frame
Rasakshay in post covid -19 syndromeTimepoint: day 0 and day 21

Secondary

MeasureTime frame
Functional status Scale in post covid -19 patientsTimepoint: day 0 and day 21

Countries

India

Contacts

Public ContactChinmayee Pravin joshi

Smt.K.C.Ajmera ayurved mahavidyalay dhule. Maharashtra

ashtang.ayur.pharma@gmail.com8669154827

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026